Your Top 10 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update
Toni K. Choueiri, Colin Hessel, Susan Halabi, Ben L. Sanford, Marc Dror Michaelson, Olwen Mary Hahn and 10 more
- Rank
- 3 of 981
- Percentile
- top 0.4%
- Where
- European Journal of Cancer, 2018
- Citations
- 400
From the 2018 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.